CDLX Cardlytics, Inc.
Services-Computer Programming, Data Processing, Etc. · Nasdaq · SEC CIK 1666071 · Fiscal year ends 12/31
Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY-25.6%
TTM net income YoY45.3%
TTM EPS YoY-368.1%
Revenue 3-yr CAGR-13.8%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-45.4%
Net margin-52.8%
FCF margin0.2%
EBITDA margin-35.3%
Returns
ROE-469.7%
ROA-33.7%
ROIC (approx.)-33.0%
Asset turnover0.64x
Leverage & solvency
Liabilities / assets106.8%
Debt / equity—
Current ratio1.62x
Interest coverage8.54x
Cash quality & payout
Operating cash flow / net income-0.01x
Accruals ratio-33.8%
Payout ratio—
Capex / revenue0.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $233.27M | $278.30M |
| R&D expense | $39.77M | $49.61M |
| SG&A expense | $47.27M | $56.48M |
| Operating income | -$101.82M | -$195.50M |
| Interest expense | -$10.60M | $8.90M |
| Pretax income | -$103.49M | -$189.30M |
| Income tax | $0 | $0 |
| Net income | -$103.49M | -$189.30M |
| EBITDA | -$76.57M | -$169.81M |
| EPS (basic) | -1.95 | -3.91 |
| EPS (diluted) | -1.95 | -3.91 |
| Weighted avg. shares (diluted) | 53.11M | 48.36M |
| Balance sheet | ||
| Cash & equivalents | $48.72M | $65.59M |
| Short-term investments | $0 | — |
| Receivables | $82.46M | $103.25M |
| Current assets | $137.28M | $177.98M |
| PP&E, net | $1.93M | $2.60M |
| Goodwill | $110.31M | $159.43M |
| Intangibles | $19.00M | $11.37M |
| Total assets | $285.64M | $392.71M |
| Current liabilities | $78.39M | $148.96M |
| Short-term debt | $0 | $45.86M |
| Long-term debt | $208.92M | $213.59M |
| Total debt | $208.92M | $259.45M |
| Total liabilities | $292.15M | $322.72M |
| Shareholders' equity | -$6.51M | $69.99M |
| Net debt | $160.20M | $193.86M |
| Shares outstanding | 5.45M | 51.26M |
| Cash flow statement | ||
| Operating cash flow | $9.29M | -$8.82M |
| Capital expenditure | $480,000 | $1.56M |
| Free cash flow | $8.81M | -$10.39M |
| Investing cash flow | -$15.30M | -$18.75M |
| Financing cash flow | -$11.12M | $1.44M |
| Depreciation & amortization | $25.24M | $25.69M |
| Stock-based compensation | $28.13M | $40.37M |
| Share buybacks | — | $0 |
Free plan shows the latest 2 periods; Pro shows all 10 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.